The global bionic eye market size is estimated at USD 382.91 billion in 2024, grew to USD 437.29 million in 2025 and is predicted to surpass around USD 1444.64 million by 2034, expanding at a CAGR of 14.20% between 2024 and 2034. The North America bionic eye market size accounted for USD 176.14 million in 2024 and is anticipated to grow at a fastest CAGR of 14.21% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Bionic Eye Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Bionic Eye Market Revenue and Volume, by Type, 2024-2034
8.1.1 External Eye
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Implanted Eye
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Bionic Eye Market Revenue and Volume, by Technology, 2024-2034
9.1.1. Electronic
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Mechanical
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1. Bionic Eye Market Revenue and Volume, by End Users, 2024-2034
10.1.1. Hospitals
10.1.1.1. Market Revenue and Volume Forecast (2021-2034)
10.1.2. Ophthalmic Clinics
10.1.2.1. Market Revenue and Volume Forecast (2021-2034)
10.1.3. Others
10.1.3.1. Market Revenue and Volume Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.1.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.1.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.1.4.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.1.4.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.1.5.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.1.5.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.2.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.2.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.2.4.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.2.4.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.2.5.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.2.5.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.2.6.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.2.6.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.2.7.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.2.7.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.3.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.3.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.3.4.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.3.4.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.3.5.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.3.5.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.3.6.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.3.6.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.3.7.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.3.7.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.4.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.4.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.4.4.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.4.4.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.4.5.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.4.5.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.4.6.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.4.6.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.4.7.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.4.7.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.5.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.5.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.5.4.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.5.4.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
11.5.5.2. Market Revenue and Volume Forecast, by Technology (2021-2034)
11.5.5.3. Market Revenue and Volume Forecast, by End Users (2021-2034)
12.1. Second Sight Medical Products, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Pixium Vision
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Retina Implant AG
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Bionic Vision Australia
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. iBionics
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Nano Retina
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. The Johns Hopkins University
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. MicroOptical
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Bionic Eye Technologies
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Optobionics Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample